Aqua Gen is a selective breeding company which develops, produces and delivers genetic material to the global sea-farming industry. Through a market-oriented research and development Aqua Gen has achieved a leading position as a provider of fertilized eggs of Atlantic salmon and rainbow trout.
Aqua Gen owns and preserves the world’s most refined genetic material from Atlantic salmon and rainbow trout. Since the 1970’s when collection of these fish species began, a continual research and development program has been carried on in cooperation with commercial operators and research institutions. By focusing on genetic traits related to health, animal welfare, growth and quality, Aqua Gen contributes an important component of a sustainable and profitable aquaculture industry.
Aqua Gen’s vision: The independent and leading provider of innovative genetic and biological products to the global aquaculture industry.
2013 - EW Groups buys 42.6% of the shares of Investment Skretting AS, Marine Harvest Norway AS, Marine Harvest Holding AS and Cermaq ASA. This triggers pre-emption rights and purchase of the remaining shares in AquaGen. EW Group now owns 100% of the shares in AquaGen AS - See more at: http://aquagen.no/en/about-aquagen/history/#sthash.6aa3HNHN.dpuf
March 04, 2014 - Australis Seafoods confirmed the sale of the assets of its salmon egg and genetic production firm Landcatch Chile SA to the company AquaGen, from Norway.
According to the notice sent by the company to the Superintendency of Securities and Insurance (SVS), the final sale price of the assets involved in the transaction reached USD 11.4 million and its net worth was USD 10.2 million.
IOTC takes action in Indonesia United Kingdom
Decision makers meeting at the annual session of the Indian Ocean Tuna Commission in Indonesia considered 16 proposals aimed at enhancing the management of the tuna fisheries in the Indian Ocean, which was encouraging by the International Pole & Line Foundation.